Company Filing History:

6 out of 289

Fred Hutchinson Cancer Center

patents

2 out of 512

Sloan-kettering Institute for Cancer Research

patents

1 out of 559

Memorial Sloan Kettering Cancer Center

patents

4. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2018

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9889135 - Companion diagnostic for CDK4 inhibitors (2018-02-13),

2. 6972170 - Markers for prostate cancer (2005-12-06),

3. 6635450 - Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agents (2003-10-21),

4. 6355774 - Isolated p27 protein (2002-03-12),

5. 6316208 - Methods for determining isolated p27 protein levels and uses thereof (2001-11-13),

6. 6242575 - Antibodies for detecting p27 protein (2001-06-05),

7. 5861259 - Immunoassays for human cyclin E (1999-01-19),

8. 5807698 - Human cyclin E (1998-09-15),

9. 5783661 - Human cyclin E polypeptides (1998-07-21),

10. 5688665 - Isolated nucleic acid molecules encoding the p27 KIP-1 protein (1997-11-18),

11. 5645999 - Assays for compounds that modulate or alter cyclin E activity (1997-07-08),

12. 5449755 - Human cyclin E (1995-09-12),

Title: Innovator Spotlight: Andrew C Koff

Introduction:

Andrew C Koff is a prolific inventor based in Seattle, WA, with an impressive portfolio of 12 patents to his name. His groundbreaking work in the field of cancer diagnostics and treatment has solidified his position as a leading figure in the medical innovation landscape.

Latest Patents:

1. Companion diagnostic for CDK4 inhibitors: Andrew's invention focuses on using biomarkers to assess the effectiveness of CDK4 inhibitors in combating cancer. By identifying cellular senescence through decreased MDM2 protein levels, this diagnostic tool revolutionizes cancer treatment evaluation.

2. Markers for prostate cancer: Andrew's patent introduces a method for determining the aggressiveness of prostate carcinoma by detecting p27 protein levels. This innovation not only aids in diagnosing benign prostate hyperplasia but also offers crucial insights into prostate cancer management.

Career Highlights:

Andrew C Koff has made significant contributions to the field of oncology through his work at prestigious institutions such as the Fred Hutchinson Cancer Research Center. His dedication to advancing cancer research and treatment has garnered widespread recognition within the scientific community.

Collaborations:

Throughout his career, Andrew has collaborated with esteemed professionals, including James M Roberts and Kornelia Polyak. These partnerships have resulted in groundbreaking discoveries and innovative solutions in the fight against cancer.

Conclusion:

In conclusion, Andrew C Koff's inventive spirit and unwavering commitment to medical innovation have transformed the landscape of cancer diagnostics and treatment. His visionary approach to research continues to inspire and drive progress in the field of oncology, making him a key figure in the pursuit of a world free from the burden of cancer.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.